DYSPORT AESTHETIC Poudre pour solution Kanada - ranska - Health Canada

dysport aesthetic poudre pour solution

ipsen biopharmaceuticals canada inc - abobotulinumtoxinea - poudre pour solution - 300unité - abobotulinumtoxinea 300unité - other miscellaneous therapeutic agents

Lantus solution injectable en cartouche Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

lantus solution injectable en cartouche

sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable en cartouche - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabète sucré - biotechnologika

Apidra solution injectable Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

apidra solution injectable

sanofi-aventis (suisse) sa - insulinum glulisinum - solution injectable - insulinum glulisinum 3.49 mg corresp. insulinum glulisinum 100 u., metacresolum, trometamolum, natrii chloridum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabilia q.s. ad solutionem pro 1 ml corresp. natrium 1.97 mg. - diabète sucré chez l'adulte - biotechnologika

Suliqua 100/50 solution injectable Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

suliqua 100/50 solution injectable

sanofi-aventis (suisse) sa - insulinum glarginum, lixisenatidum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., lixisenatidum 50 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika

Suliqua 100/33 solution injectable Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

suliqua 100/33 solution injectable

sanofi-aventis (suisse) sa - insulinum glarginum, lixisenatidum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., lixisenatidum 33 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika

Tresiba Penfill Solution injectable Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

tresiba penfill solution injectable

novo nordisk pharma ag - insulinum degludecum - solution injectable - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Tresiba FlexTouch 100 E/ml Solution injectable Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

tresiba flextouch 100 e/ml solution injectable

novo nordisk pharma ag - insulinum degludecum - solution injectable - insulinum degludecum 600 nmol corresp. insulinum degludecum 100 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Tresiba FlexTouch 200 E/ml Solution injectable Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

tresiba flextouch 200 e/ml solution injectable

novo nordisk pharma ag - insulinum degludecum - solution injectable - insulinum degludecum 1200 nmol corresp. insulinum degludecum 200 u., glycerolum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika

Insulin NovoNordisk NovoRapid PumpCart 100 E/ml Solution injectable Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

insulin novonordisk novorapid pumpcart 100 e/ml solution injectable

novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u., glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, phenolum, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.216 mg. - le diabète sucré - biotechnologika

Insulin Lilly Huminsulin Basal KwikPen stylo prérempli suspension injectable Sveitsi - ranska - Swissmedic (Swiss Agency for Therapeutic Products)

insulin lilly huminsulin basal kwikpen stylo prérempli suspension injectable

eli lilly (suisse) sa - insulinum humanum adnr isophanum - suspension injectable - insulinum humanum adnr isophanum 100 u.i., metacresolum, glycerolum, phenolum, protamini sulfas, dinatrii phosphas heptahydricus, zinci oxidum, acidum hydrochloridum dilutum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 0.6 mg. - diabète sucré - biotechnologika